Search results
Palatin Initiates Phase 2 Clinical Study of Bremelanotide for the Treatment of Obesity
NBC 17 Raleigh· 3 days agoPalatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system ...
Economic development in sub-Saharan Africa is linked to increasing obesity rates in women
The Conversation· 6 days agoObesity and excess weight gain, traditionally perceived as health issues predominantly affecting high-income countries, are now increasingly prevalent in low and middle-income regions. Sub-Saharan ...